Jonathan Levenson
Company: Tiaki Therapeutics
Job title: Vice President of Translational Biology
Bio:
Jonathan Levenson is the VP of Translational Biology at Tiaki Therapeutics. He previously served as the VP of preclinical research and development at Proclara, where he oversaw two preclinical programs characterizing novel biological therapeutics targeting misfolded proteins in neurodegenerative, orphan and metabolic disease. Prior to joining Proclara, he worked at Galenea, a drug development company focusing on the cognitive symptoms of psychiatric disorders, where he held positions of increasing responsibility, culminating in the role of senior scientist. Before that, Dr. Levenson was an assistant professor and the director of the rodent behavioral core at the University of Wisconsin-Madison. He was previously a consultant at Saegis Pharmaceuticals and an assistant professor at Baylor College of Medicine.
Dr. Levenson earned his Bachelor of Science, cum laude, from Vanderbilt University, his doctorate in Biology from the University of Houston, and was a postdoctoral fellow at the Baylor College of Medicine. He has authored or co-authored over 60 research publications focused on neuropharmacology and the treatment of neurological diseases.
Seminars:
Live Q&A – Fire Away & Ask Those Questions! 4:05 pm
day: One-Day Digital Content
Finding the Right Patients: Can Genetics Inform Selection of Fluid Biomarkers that Identify Subjects with a Specific Disease Biology? 3:45 pm
Heterogeneity in patient populations is likely due, in part, to heterogeneity in disease biology There is a need for biomarkers that can identify patients with a common disease biology An approach that leverages genetics and bioinformatics can be used to find new biomarkers and new uses for existing biomarkers. Read more
day: One-Day Digital Content